Price T Rowe Associates Inc. MD Raises Stock Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Price T Rowe Associates Inc. MD grew its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 13.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,518 shares of the biotechnology company’s stock after buying an additional 1,781 […]
Price T Rowe Associates Inc. MD grew its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 13.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,518 shares of the biotechnology company’s stock after buying an additional 1,781 […]
